We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$19.2B
AUM Growth
+$2.52B
Cap. Flow
+$1.25B
Cap. Flow %
6.54%
Top 10 Hldgs %
17.34%
Holding
2,313
New
197
Increased
1,021
Reduced
855
Closed
212

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 15.67%
3 Healthcare 9.34%
4 Consumer Discretionary 9.15%
5 Real Estate 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXAS
676
DELISTED
Exact Sciences
EXAS
$5.15M 0.03%
66,178
+6,184
+10% +$546K
WPM icon
677
Wheaton Precious Metals
WPM
$60.9B
$5.13M 0.03%
119,533
-54,656
-31% -$2.25M
FDS icon
678
Factset
FDS
$10.2B
$5.11M 0.03%
10,513
+5,899
+128% +$2.65M
IQV icon
679
IQVIA
IQV
$39.3B
$5.11M 0.03%
18,101
+2,632
+17% +$683K
AES icon
680
AES
AES
$10.5B
$5.11M 0.03%
210,134
+4,972
+2% +$121K
TAP icon
681
Molson Coors Class B
TAP
$8.09B
$5.1M 0.03%
109,946
-12,943
-11% -$594K
CMC icon
682
Commercial Metals
CMC
$8.31B
$5.1M 0.03%
140,415
-38,706
-22% -$1.28M
HBAN icon
683
Huntington Bancshares
HBAN
$35.5B
$5.08M 0.03%
329,559
-50,122
-13% -$790K
CTRA
684
DELISTED
Coterra Energy
CTRA
$5.06M 0.03%
266,152
+29,802
+13% +$622K
PBCT
685
DELISTED
People's United Financial Inc
PBCT
$5.03M 0.03%
282,464
-40,322
-12% -$719K
GPN icon
686
Global Payments
GPN
$22.8B
$4.99M 0.03%
36,931
+19,636
+114% +$2.71M
EOS
687
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
$4.97M 0.03%
202,295
+10,745
+6% +$259K
BIO icon
688
Bio-Rad Laboratories Class A
BIO
$9.42B
$4.97M 0.03%
6,581
-6,459
-50% -$4.83M
KR icon
689
Kroger
KR
$34.8B
$4.95M 0.03%
109,418
-47,189
-30% -$1.98M
EOD
690
Allspring Global Dividend Opportunity Fund
EOD
$286M
$4.94M 0.03%
837,986
+452,918
+118% +$2.62M
ES icon
691
Eversource Energy
ES
$27.2B
$4.93M 0.03%
54,231
-25,325
-32% -$2.18M
BNY
692
Bank of New York Mellon
BNY
$107B
$4.92M 0.03%
84,745
-2,931
-3% -$169K
ECL icon
693
Ecolab
ECL
$79.9B
$4.91M 0.03%
20,922
+3,530
+20% +$798K
RJF icon
694
Raymond James Financial
RJF
$34B
$4.9M 0.03%
48,819
+7,228
+17% +$714K
HIO
695
Western Asset High Income Opportunity Fund
HIO
$340M
$4.9M 0.03%
942,306
+443,026
+89% +$2.29M
NXP icon
696
Nuveen Select Tax-Free Income Portfolio
NXP
$900M
$4.9M 0.03%
306,501
+181,095
+144% +$2.99M
PKG icon
697
Packaging Corp of America
PKG
$22.8B
$4.87M 0.03%
35,765
+15,191
+74% +$2.04M
EQH icon
698
Equitable Holdings
EQH
$14.1B
$4.85M 0.03%
147,876
-4,918
-3% -$161K
TTD icon
699
Trade Desk
TTD
$6.49B
$4.83M 0.03%
52,715
+42,202
+401% +$3.7M
EXEL icon
700
Exelixis
EXEL
$13.4B
$4.83M 0.03%
264,252
-72,608
-22% -$1.39M

Similar funds

Guggenheim Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Guggenheim Capital held 2,313 positions worth $19.2B, up 15% from $16.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Guggenheim Capital deployed $1.25B of net new capital in Q4 2021, opening 197 new positions and adding to 1,021 existing holdings. Its largest new stake was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Tesla, an estimated $28.7M trimmed.

  • Guggenheim Capital's largest Q4 2021 buy was AfterNext HealthTech Acquisition Corp: 3,725,000 shares worth $36.3M.
  • Guggenheim Capital added most to FIGS in Q4 2021, an estimated $173M increase.
  • Guggenheim Capital's biggest Q4 2021 reduction was Tesla, cutting an estimated $28.7M.
  • Guggenheim Capital fully exited AfterNext HealthTech Acquisition Corp Units in Q4 2021, selling an estimated $37.1M.
  • Guggenheim Capital's ten largest holdings make up 17% of its $19.2B portfolio in Q4 2021.
  • Guggenheim Capital opened 197 new positions and closed 212 in Q4 2021.
  • Guggenheim Capital's portfolio value rose 15% quarter-over-quarter to $19.2B.

Based on Guggenheim Capital's 13F filing for Q4 2021, filed 14 Feb 2022.